ABSCI CORP (ABSI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ABSI • US00091E1091

2.6 USD
-0.04 (-1.52%)
At close: Feb 11, 2026
2.62 USD
+0.02 (+0.77%)
Pre-Market: 2/12/2026, 6:27:02 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ABSI. ABSI was compared to 523 industry peers in the Biotechnology industry. While ABSI seems to be doing ok healthwise, there are quite some concerns on its profitability. ABSI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ABSI has reported negative net income.
  • ABSI had a negative operating cash flow in the past year.
  • In the past 5 years ABSI always reported negative net income.
  • ABSI had a negative operating cash flow in each of the past 5 years.
ABSI Yearly Net Income VS EBIT VS OCF VS FCFABSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -46.78%, ABSI is in line with its industry, outperforming 53.15% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -54.49%, ABSI is in the better half of the industry, outperforming 64.63% of the companies in the same industry.
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROIC N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ABSI Yearly ROA, ROE, ROICABSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ABSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABSI Yearly Profit, Operating, Gross MarginsABSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ABSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ABSI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ABSI has more shares outstanding
  • The debt/assets ratio for ABSI has been reduced compared to a year ago.
ABSI Yearly Shares OutstandingABSI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ABSI Yearly Total Debt VS Total AssetsABSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 2.49 indicates that ABSI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ABSI (2.49) is better than 67.30% of its industry peers.
  • ABSI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • ABSI has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.49
ROIC/WACCN/A
WACC12.39%
ABSI Yearly LT Debt VS Equity VS FCFABSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • ABSI has a Current Ratio of 5.89. This indicates that ABSI is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ABSI (5.89) is better than 61.38% of its industry peers.
  • A Quick Ratio of 5.89 indicates that ABSI has no problem at all paying its short term obligations.
  • ABSI has a better Quick ratio (5.89) than 62.72% of its industry peers.
Industry RankSector Rank
Current Ratio 5.89
Quick Ratio 5.89
ABSI Yearly Current Assets VS Current LiabilitesABSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.64% over the past year.
  • Looking at the last year, ABSI shows a very negative growth in Revenue. The Revenue has decreased by -33.09% in the last year.
  • The Revenue has been growing by 17.09% on average over the past years. This is quite good.
EPS 1Y (TTM)3.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-33.09%
Revenue growth 3Y-1.75%
Revenue growth 5Y17.09%
Sales Q2Q%-77.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.23% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 63.29% on average over the next years. This is a very strong growth
EPS Next Y8.18%
EPS Next 2Y11.08%
EPS Next 3Y11.19%
EPS Next 5Y12.23%
Revenue Next Year-18.65%
Revenue Next 2Y83.31%
Revenue Next 3Y79.19%
Revenue Next 5Y63.29%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABSI Yearly Revenue VS EstimatesABSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ABSI Yearly EPS VS EstimatesABSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ABSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ABSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABSI Price Earnings VS Forward Price EarningsABSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABSI Per share dataABSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.08%
EPS Next 3Y11.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ABSI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ABSCI CORP

NASDAQ:ABSI (2/11/2026, 8:05:07 PM)

Premarket: 2.62 +0.02 (+0.77%)

2.6

-0.04 (-1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners66.04%
Inst Owner Change0.98%
Ins Owners6.25%
Ins Owner Change0.33%
Market Cap390.96M
Revenue(TTM)2.81M
Net Income(TTM)-114.60M
Analysts82.67
Price Target8.21 (215.77%)
Short Float %27.44%
Short Ratio10.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.81%
Min EPS beat(2)-10.99%
Max EPS beat(2)7.37%
EPS beat(4)2
Avg EPS beat(4)1.03%
Min EPS beat(4)-10.99%
Max EPS beat(4)10.49%
EPS beat(8)2
Avg EPS beat(8)-2.82%
EPS beat(12)3
Avg EPS beat(12)-7.95%
EPS beat(16)3
Avg EPS beat(16)-8%
Revenue beat(2)0
Avg Revenue beat(2)-66.07%
Min Revenue beat(2)-77.45%
Max Revenue beat(2)-54.7%
Revenue beat(4)0
Avg Revenue beat(4)-51.89%
Min Revenue beat(4)-77.45%
Max Revenue beat(4)-12.08%
Revenue beat(8)0
Avg Revenue beat(8)-46.62%
Revenue beat(12)1
Avg Revenue beat(12)-43.85%
Revenue beat(16)2
Avg Revenue beat(16)-38.63%
PT rev (1m)-2.56%
PT rev (3m)2.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)0%
EPS NY rev (3m)2.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 138.89
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 2.33
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.02
BVpS1.4
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.15%
Cap/Sales 43.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.89
Quick Ratio 5.89
Altman-Z 2.49
F-Score3
WACC12.39%
ROIC/WACCN/A
Cap/Depr(3y)44.41%
Cap/Depr(5y)179.67%
Cap/Sales(3y)101.78%
Cap/Sales(5y)229.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y8.18%
EPS Next 2Y11.08%
EPS Next 3Y11.19%
EPS Next 5Y12.23%
Revenue 1Y (TTM)-33.09%
Revenue growth 3Y-1.75%
Revenue growth 5Y17.09%
Sales Q2Q%-77.78%
Revenue Next Year-18.65%
Revenue Next 2Y83.31%
Revenue Next 3Y79.19%
Revenue Next 5Y63.29%
EBIT growth 1Y-15.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.25%
EBIT Next 3Y-18.87%
EBIT Next 5Y-3.11%
FCF growth 1Y-17.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.2%
OCF growth 3YN/A
OCF growth 5YN/A

ABSCI CORP / ABSI FAQ

What is the ChartMill fundamental rating of ABSCI CORP (ABSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ABSI.


Can you provide the valuation status for ABSCI CORP?

ChartMill assigns a valuation rating of 0 / 10 to ABSCI CORP (ABSI). This can be considered as Overvalued.


How profitable is ABSCI CORP (ABSI) stock?

ABSCI CORP (ABSI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ABSI stock?

The Earnings per Share (EPS) of ABSCI CORP (ABSI) is expected to grow by 8.18% in the next year.